Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Reexamination Certificate
2005-04-26
2005-04-26
Kemmerer, Elizabeth (Department: 1647)
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
C424S085400, C514S002600, C514S012200, C530S351000
Reexamination Certificate
active
06884411
ABSTRACT:
Use of natural human α-interferon for the preparation of a medicament in liquid form to be administered through peroral route at dosages comprised between 100 UI and 500 UI/day, for therapy of viral infections, in particular viral hepatitis, neoplasia and immune diseases in humans and animals.
REFERENCES:
patent: 5824300 (1998-10-01), Cummins
patent: 5849696 (1998-12-01), Chretien et al.
patent: 5980884 (1999-11-01), Blatt et al.
patent: 6001799 (1999-12-01), Chretien et al.
patent: 6048843 (2000-04-01), Toth
patent: 1005868 (2000-06-01), None
patent: 8803411 (1988-05-01), None
Toyoda et al. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol 89(9): 1453-1457, 1994.*
Di Bisceglie et al. Recombinant interferon alfa therapy for chronic hepatitis C. New England J Med 321:1506-1510, 1989.*
Davis et al. Treatment of chronic hepatitis C with recombinant interferon alfa. New England J Med 321: 1501-1506, 1989.*
Main, J. Future studies of combination therapy for chronic hepatitis C: optimizing response rates for each hepatitis C population. J Hepatology (Suppl) 23(2): 32-36, 1995.*
Marcellin et al. Recombinant human alpha-interferon in patients with chronic non-a, non-b hepatitis: a multicenter randomized controlled trial from France. Hepatology 13: 393-397, 1991.*
Archivum Immunologiae et Therapiae Experimentalis 41(3-4). 1993: 259-265, J.A. Georgiades; “Early changes in the plasma proteins of patients treated with low doses of oral natural human interferon alpha (IFN-alpha)”.
Archivum Immunologiae et Therapiae Experimentalis 41(3-4). 1993; 237-240. B. Ratajczak; “Observation of the effect of low oral doses of human leukocytic interferon alpha in children with chronic HBV infection and impaired immune response”.
Archivum Immunologiae et Therapiae Experimentalis 44 (5-6); 1996; 359-366.; Zielinska et al: “Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients”.
Brozzo Renzo
Tarro Giulio
Baker & Botts LLP
Bunner Bridget E.
Kemmerer Elizabeth
Unihart Corporation
LandOfFree
Method of treating viral hepatitis by administration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating viral hepatitis by administration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating viral hepatitis by administration of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3401766